SLD vs SPL

ASX Healthcare sector comparison — updated 22 Jul 2026 — Healthcare sector

SLD

SALUDA MED CDI FORUS [SLD]

50MEDIUM

SPL

STARPHARMA FPO [SPL]

51MEDIUM

Score Breakdown

SLD SPL
Technical
55
40
Catalyst
51
70
Sentiment
50
50
Fundamental
66
47
Momentum
31
77
Risk Gate
50
45

Key Metrics

SLD Metric SPL
N/AMarket Cap$306.8M
661KAvg Volume (20d)1.1M
+0.1%Short Interest+0.1%
$1.90052-Week High$0.790
$0.36052-Week Low$0.094
-1.9%Daily Change-1.4%
$0.525Reference Price$0.700
N/AROE-14.5%
-213.8%Profit Margin-22.2%

Active Signals

SLD Signals

Stochastic turning bearish from a high level — caution
Trading above both moving averages — the trend is your friend here
Beating the Small Ords index — relative strength of 1.30, so it's outpacing the pack
Adequate cash runway (5 quarters)
Moderate revenue growth (+17%)
Near 52-week low (11% of range)
CANSLIM I: Institutional ownership (31%)
Deeply negative margins (-214%)

SPL Signals

MACD momentum is losing steam
Volume surging at 2.3x normal while price falls — heavy selling pressure
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Trading above the 200-day average — the long-term trend is on your side
Strong cash runway (86 quarters)
Strong revenue growth (+360%)
Piotroski F-Score weak (3/9, low-confidence approx)
Substantial holder(s) ceased (1)

Ask Scout AI to compare SLD and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

SLD vs TRJ →SLD vs TRP →SNT vs TRJ →SNT vs VIT →SOM vs SPL →
SLD Full Analysis → SPL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).